Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine and Focalin XR Combination for ADHD in Children
NCT00429273Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2007
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of guanfacine, methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University of California, Los Angeles. Started Jan 2007; status: completed.
02
Drugs
guanfacinemethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00429273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429273.